Blood pressure meds promote muscle growth in frail elderly, study says

Seniors fighting muscle weakness could be helped by widely available blood pressure medications, according to new research.

As people age, the blood vessels that supply muscles with the amino acids they need to grow become less responsive and less able to do their jobs, according to researchers at the University of Texas Medical Branch at Galveston. In a small study involving 12 healthy older adults, researchers found that the “vasodilator” sodium nitroprusside, a drug used in hospitals to fight high blood pressure, was effective in dilating the blood vessels, increasing the flow of nutrients to the muscle.

"By giving them this vasodilator, we were able to make our 70-year-olds look like 30-year-olds, at least in terms of muscle growth," said lead author Kyle Timmerman. His team cautioned that broader research would be needed to confirm its findings.

This results complement earlier UTMB research, which found that elevated levels of insulin also dilate the blood vessels and promote better muscle growth among the elderly (McKnight's, 9/28/09). The more recent study appears in the online version of the journal Diabetes.

More in News

Government agency launches health IT webpage for long-term care providers

Government agency launches health IT webpage for long-term ...

The Office of the National Coordinator for Health Information Technology has unveiled a new webpage with information and resources for long-term and post-acute (LTPAC) providers.

FDA responds to provider pressure, backs off stricter control of fecal transplants ...

Individuals with treatment-resistant Clostridium difficile can undergo fecal transplants after giving informed consent, the Food and Drug Administration recently announced. This is a victory for providers, who pushed back after the FDA recently announced it would tighten regulations around the transplants.

Judge denies Omnicare's 'untimely' motion to disqualify whistleblower in nursing home kickbacks ...

Omnicare has failed to disqualify a whistleblower who alleges the long-term care pharmacy paid kickbacks to nursing homes, ruled a district court judge.